Triple-negative breast cancer (TNBC) is a hypotype of breast cancer that is immunohistochemically based on the negative expression of the hormone receptors estrogen receptor (ER) and progesterone receptor (PR) and on the negative amplification of HER2 amplification[1]. Here, ESR1 is linked to breast carcinoma.